First National Daily eMedical Newspaper of India
Nobody Reports News Better Than Us  
Editorial
We have improved our eMediNexus Platform with a far superior user experience.
Please click here to try it
Editor-in-Chief eMediNexus – Dr KK Aggarwal
Editor-in-Chief eIMANews - Dr Ravi Wankhedkar
17th February, 2018
Dr Bawa Garba Case: Indian doctors need immunity while reporting adverse events

The historical manslaughter conviction of a UK doctor related to a case in which a six-year-old boy died at Leicester Royal Infirmary in 2011 that found her guilty of manslaughter by gross negligence in 2015, has opened a large number of issues of importance to Indian medical practice.

One of the issues of concern is the handling of Dr Bawa-Garba's case linked to reflective writing from her e-portfolio, which was reported to have been used in evidence. Though her medical defence organization has made clear that information from the e-portfolio was not used but notes made by her duty consultant on a meeting with Dr Bawa-Garba after the event to discuss and learn from it, formed part of his witness statement. .... read more

Special
Top News

First human case of H7N4 bird flu reported in China

China has reported the first human case of the H7N4 strain of bird flu in a woman in an eastern coastal province, though she has since recovered. The winter is traditionally the high season for bird flu infections. In a statement late on Wednesday, the Hong Kong government’s Centre for Health Protection said it had informed of the case by mainland China’s health ministry, the National Health and Family Planning Commission.... read more


48% dip in Indian doctors who went overseas in 2017

BENGALURU: In what must come as good news to a stretched healthcare system, the number of doctors going abroad dipped by 48% in 2017 compared to the previous year and 51% over 2015.Doctors say policy changes in western countries such as US and UK have made it tougher for Indians there while the improving infrastructure and.... read more

Practice Updates

First FDA-approved treatment for non-metastatic, castration-resistant prostate cancer

The US Food and Drug Administration has approved Erleada (apalutamide) for the treatment of patients with prostate cancer that has not spread (non-metastatic), but that continues to grow despite treatment with hormone therapy (castration-resistant)..... read more


Short kids may have higher future stroke risk

Being a short kid is associated with increased risk of having a stroke in adulthood, according to a new research published February 15, 2018 in the journal Stroke. Such children should pay extra attention to changing or treating modifiable risk factors.... read more


New guidelines on understanding and managing immunotherapy side effects

The American Society of Clinical Oncology (ASCO) and the National Comprehensive Cancer Network (NCCN), leading Cancer Organizations have collaborated to develop recommendations for assessment and management of side effects related to immune checkpoint inhibitors.... read more


Avoid highly processed foods to reduce overall risk of cancer

A 10% increase in the proportion of highly processed foods such as packaged baked goods, instant soups, reconstituted meats, frozen meals, and shelf-stable snacks in diet was associated with a significant increase of greater than 10% in risks of overall and breast cancer,... read more


Low systolic BP in HFpEF patients increases mortality

Results of an observational study show that a systolic blood pressure level less than 120 mm Hg in hospitalized older people with heart failure with preserved ejection fraction (HFpEF) is independently associated with higher risk for short- and long-term mortality and readmissions..... read more


Levetiracetam superior to phenobarbital as initial monotherapy of nonsyndromic epilepsy in infants

Levetiracetam may be more effective than phenobarbital for first-line monotherapy of infantile epilepsy, says a study published online February 12, 2018 in JAMA Pediatrics. In infants with nonsyndromic epilepsy, freedom from monotherapy failure at 6 months was significantly more common for children treated with levetiracetam.... read more

Cardiology Updates

Does serum albumin level have an effect on neurological outcome after out-of-hospital cardiac arrest?

A prospective, multicenter observational study that analyzed whether serum albumin concentration upon hospital arrival had prognostic indications on out-of-hospital cardiac.... read more


Is transcatheter tricuspid valve-in-valve implantation a good option in patients with Ebstein anomaly?

A study published in the American Journal of Cardiology determined the acute results and short- to medium-term durability of transcatheter.... read more

eMedi Humor
Medicolegal Corner
eMedi Quiz
a) It has a better prognosis.
b) It is related to disease activity.
c) It is related to duration of ulcerative colitis.
d) Malignancy is more in anorectal ulcerative colitis.
Lifestyle Updates
 
Inspirational Story 2: The Comfort Zone
More concentrated efforts will be needed to achieve the target of TB elimination
Contact tracing and timely reporting form the basis of eradication
 
New Delhi, 16th February 2018: The National Health Policy has a target of eliminating tuberculosis (TB) by 2025. This means that there should not be more than one case of TB for a population of 1 lakh. For India to eliminate this disease by the estimated deadline, the rate of decline of cases needs to be 21% per year over 8 years. However, with the current rate of annual decline of TB cases globally standing at 1.5%, India is lagging in its national decline rate.
 
WHO’s Global TB Report 2017 highlights that under-reporting and under-diagnosis of TB cases continue to be a challenge, especially in countries with large unregulated private sectors and weak health systems, including India.
To Read More or Comment, Click Here